相关实验视频
Updated: Jul 2, 2025

04:49
Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
457
希望对阵希望的比赛 作I:扩散的α-synuclein解释了帕金森病的认知缺陷
Kelly A Mills1, Oliver Phillips2, Abhimanyu Mahajan3
1Johns Hopkins Department of Neurology, Baltimore, MD600 N. Wolfe Street, Meyer 6-181D, 21287, United States.
Parkinsonism & related disorders
|February 16, 2024
概括
帕金森病的管理是辩论,专注于是否阿尔法-同核素传播导致认知缺陷. 专家们在"作与希望"系列中提出了支持和反对这一理论的论点.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 运动障碍 运动障碍
背景情况:
- 帕金森研究小组召集专家讨论目前的帕金森病管理.
- 这是关于帕金森病研究中的"作与希望"系列文章中的第一篇.
- 辩论的重点是关于帕金森病的有争议的趋势和进展.
研究的目的:
- 提出关于α-synuclein在帕金森病认知缺陷中的作用的辩论.
- 为了探索"同意"和"不同意"的立场"扩散的α-synuclein解释了帕金森病的认知缺陷"提示.
- 将一个科学辩论改编成一个观点文章.
主要方法:
- 专家们在一个特定的提示上被分配了"同意"或"不同意"的立场.
- 辩论的重点是提示:"扩散α-synuclein解释了帕金森病的认知缺陷.
- 这篇文章是对此专家辩论的改编.
主要成果:
- 凯利·米尔斯博士主张提醒 (同意).
- 博士Abhimanyu Mahajan反对提示 (不同意).
- 这篇文章介绍了关于α-synuclein在认知障碍中的作用的两种观点.
结论:
- 辩论强调了了解帕金森病的持续争议.
- 需要进一步的研究来澄清α-synuclein与认知衰退之间的联系.
- 这次讨论有助于塑造未来对帕金森病的管理.
相关概念视频
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K

